Cox, Jennifer G. http://orcid.org/0000-0003-0177-5724
de Groot, Marius http://orcid.org/0000-0003-0154-1397
Cole, James H. http://orcid.org/0000-0003-1908-5588
Williams, Steven C. R. http://orcid.org/0000-0003-4299-1941
Kempton, Matthew J. http://orcid.org/0000-0003-3541-9947
Article History
Received: 26 September 2022
Revised: 1 December 2022
Accepted: 9 December 2022
First Online: 19 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Jennifer Cox is an industry-funded PhD student funded by GlaxoSmithKline.Dr. de Groot is an employee of and holds shares in GlaxoSmithKline (GSK). GSK had no role in the design or conduct of the study.Dr. Kempton was funded by an MRC Career Development Fellowship (grant MR/J008915/1).Dr. Williams has received research funding from Bionomics, Eli Lilly, the Engineering and Physical Sciences Research Council, GlaxoSmithKline, Johnson & Johnson, Lundbeck, the National Institute of Health Research, Pfizer, Takeda, and Wellcome Trust.The authors acknowledge financial support from the Wellcome Trust and the Engineering and Physical Sciences Research Council for the King’s Medical Engineering Centre and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The other authors report no financial relationships with commercial interests.
: The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.